Is FDA's Crackdown on Direct-To-Consumer Genetic Testing a Violation of the First Amendment?
In November 2013, the U.S. Food and Drug Administration (FDA) ordered the company 23andMe to stop offering its direct-to-consumer DNA testing service, which provided individuals with $99 assessments of their…